Thymic involution, a co‐morbidity factor in amyotrophic lateral sclerosis
Authors:
Open Access
- 24 July 2009
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 14 (10) , 2470-2482
Abstract
Amyotrophic lateral sclerosis (ALS) is a devastating disease, characterized by extremely rapid loss of motor neurons. Our studies over the last decade have established CD4+ T cells as important players in central nervous system maintenance and repair. Those results, together with recent findings that CD4+ T cells play a protective role in mouse models of ALS, led us to the current hypothesis that in ALS, a rapid T‐cell malfunction may develop in parallel to the motor neuron dysfunction. Here, we tested this hypothesis by assessing thymic function, which serves as a measure of peripheral T‐cell availability, in an animal model of ALS (mSOD1 [superoxide dismutase] mice; G93A) and in human patients. We found a significant reduction in thymic progenitor‐cell content, and abnormal thymic histology in 3–4‐month‐old mSOD1 mice. In ALS patients, we found a decline in thymic output, manifested in the reduction in blood levels of T‐cell receptor rearrangement excision circles, a non‐invasive measure of thymic function, and demonstrated a restricted T‐cell repertoire. The morbidity of the peripheral immune cells was also manifested in the increase of pro‐apoptotic BAX/BCXL2 expression ratio in peripheral blood mononuclear cells (PBMCs) of these patients. In addition, gene expression screening in the same PBMCs, revealed in the ALS patients a reduction in key genes known to be associated with T‐cell activity, including: CD80, CD86, IFNG and IL18. In light of the reported beneficial role of T cells in animal models of ALS, the present observation of thymic dysfunction, both in human patients and in an animal model, might be a co‐pathological factor in ALS, regardless of the disease aetiology. These findings may lead to the development of novel therapeutic approaches directed at overcoming the thymic defect and T‐cell deficiency.Keywords
This publication has 84 references indexed in Scilit:
- Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in MicePLOS Medicine, 2009
- Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)Journal of Neuroimmunology, 2009
- T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALSProceedings of the National Academy of Sciences, 2008
- CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALSProceedings of the National Academy of Sciences, 2008
- Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2006
- Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injuryProceedings of the National Academy of Sciences, 2006
- Glatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Proceedings of the National Academy of Sciences, 2006
- The many important facets of T-cell repertoire diversityNature Reviews Immunology, 2004
- Reference Intervals for Human Peripheral Blood Lymphocyte Subpopulations from ‘Healthy’ Young and Aged SubjectsInternational Archives of Allergy and Immunology, 1995
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993